The novel coronavirus originating from China has continued to spread around the world and has increased the risk of drug shortages in the U.S. as a result of dependence on Chinese drug ingredients.

UnitedHealth Group, which owns the nation’s largest health insurance provider UnitedHealthcare, has parted ways with physician staffing firm Mednax, and cut the company from its in-network providers.

The Comprehensive Care for Joint Replacement Model, which covers hip and knee joint replacement bundled payments, could see a three-year extension, CMS announced in a proposed rule.

Oscar Health has introduced a new drug formulary that will limit the cost for patients to just $3 per month for a supply of commonly used medicines, including insulin.

Private equity firms are continuing their investments in physician practices, scooping up 355 acquisitions from 2013 to 2016, according to a new study published in JAMA.

The troubles of Purdue Pharma, the maker of the opioid OxyContin, have led two hedge funds to cut ties with the company as legal consequences from the national opioid abuse and overdose epidemic continue to play out.

HHS is extending its existing partnership with pharmaceutical company Janssen Research & Development, which is part of Johnson & Johnson, to develop treatments for the 2019 novel coronavirus, the agency announced.

More Americans afflicted with chronic disease are turning to unregulated markets such as Craigslist to find insulin and other necessary medications because they can’t afford to purchase them at the pharmacy­­.